structural basis function inhibition influenza virus proton channel 
m2 protein influenza virus ph activated proton channel mediates acidification interior viral particles entrapped endosomes m2 target anti influenza drugs amantadine rimantadine; recently resistance drugs humans birds pigs reached % ref describe crystal structure transmembrane spanning region homotetrameric protein presence absence channel blocking drug amantadine ph dependent structural changes occur near set conserved trp residues involved proton gating2 drug binding site lined residues mutated amantadine resistant viruses34 binding amantadine physically occludes pore might also perturb pka critical residue structure provides starting point solving problem resistance m2 channel blockers 
